ASX/NASDAQ Announcement 18 November 2026 2026 Annual General Meeting - CEO Address Immuron Limited (ASX: IMC; NASDAQ: IMRN) attaches the CEO Address to be delivered by Chief Executive Officer, Steve Lydeamore, at today’s Annual General Meeting. - - - END - - - COMPANY CONTACT: Steven Lydeamore...
CEO Address
Filed with ASX · · 11 pages · English
Summary by 6ix AI
Immuron Limited has released the CEO Address for its Annual General Meeting, detailing the company's focus on developing targeted polyclonal antibodies for infectious diseases. The address highlights recent financial achievements, including positive revenue trends and ongoing sales growth for its product Travelan®.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/ceo-address-3
Release
In the deck
Earlier from Immuron
- Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
- Immuron Engages LifeSci Capital
- Emerging Growth Conference Presentation
- Immuron Updates At-The-Market Funding Facility
- Immuron FY27 Sales Update
Later from Immuron
All Immuron news releasesFollow Immuron into a list and get an email when it puts out news.
Follow Immuron